Latest Taxation News

Bravura Solutions has received a final Class Ruling from the Australian Taxation Office clarifying the tax treatment of its recent $0.163 per share capital return, providing certainty for shareholders holding shares on capital account.

Suncorp Group Limited has announced a cash return of capital of AUD 3.00 per share, backed by shareholder and regulatory approvals, with payments scheduled for early March 2025.

Suncorp Group Limited has announced a combined ordinary and special dividend totaling AUD 0.63 per security, fully franked and backed by APRA approval for a capital reduction. The payment is scheduled for mid-March 2025.

Spacetalk Ltd has secured a $428,853 R&D tax rebate from the Australian Taxation Office, reinforcing its commitment to innovation while reporting a 16% increase in Annual Recurring Revenue and significant cost reductions.

NoviqTech Limited has announced a non-renounceable pro-rata entitlement issue of new options aiming to raise approximately $251,000. Eligible shareholders can subscribe at a low issue price, with options exercisable over three years.

Janus Henderson Investors has announced the final distribution for its Sustainable Credit Active ETF, delivering 18.3819 cents per unit for January 2025. Key dates for investors include the ex-date on 3 February and payment on 13 February.

Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.

Top Shelf International Holdings reports a $2 million underlying EBITDA loss in Q2 FY25, while pursuing the sale of its Campbellfield facility and exploring capital raising options amid ongoing trading suspension.

Recce Pharmaceuticals has gained key regulatory and ethics approvals for its Phase 3 clinical trial in Indonesia and completed patient dosing for its Phase II trial, while securing a substantial A$6.75 million R&D tax rebate to bolster its financial position.

Careteq Limited reports solid progress in integrating its Embedded Health Solutions with HMR Referrals, alongside a 14% revenue increase and improved cash flow in Q2 FY25.

Race Oncology has advanced its Phase 1 clinical trial for RC220, submitting ethics approvals and bolstering its cash reserves to $18.78 million following a $5.25 million R&D tax incentive.

Donaco International posted modest revenue and EBITDA gains in Q2 FY2025, alongside a stronger cash position, while navigating regulatory uncertainties in Southeast Asia.